Pancreatology Template
Write in a clean editor, then format for Pancreatology in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Pancreatology format
Pancreatology is a peer-reviewed journal published by Elsevier, covering Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Neuroendocrine Tumor Research Advances.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Pancreatology 12 (2023) 45–58.
Formats any DOI in Pancreatology style. No sign-up. |
| Publishes research in | Pancreatic and Hepatic Oncology Research Pancreatitis Pathology and Treatment Neuroendocrine Tumor Research Advances Gallbladder and Bile Duct Disorders Liver Disease Diagnosis and Treatment |
| ISSN | 1424-3903 |
| Citation impact (2-yr) | 0.87 |
| h-index | 110 |
| i10-index | 1,900 |
| Total citations | 92,730 |
| Article processing charge | $3,630 |
| Top institutions publishing here | University of Szeged |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Pancreatology per year
Citation impact of Pancreatology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Pancreatology
BACKGROUND: There have been substantial improvements in the management of acute pancreatitis since the publication of the International Association of Pancreatology (IAP) treatment guidelines in 2002. A collaboration of the IAP and the American Pancreatic Association (APA) was undertaken to revise these guidelines using an evidence-based approach. METHODS: Twelve multidisciplinary review groups performed systematic literature…
This statement was developed to promote international consensus on the definition of borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC) which was adopted by the National Comprehensive Cancer Network (NCCN) in 2006, but which has changed yearly and become more complicated. Based on a symposium held during the 20th meeting of the International Association of Pancreatology (IAP)…